Cargando…
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome that occurs as a complication in many clinical settings. Malignancy-associated HLH develops in patients with hematopoietic neoplasms, particularly in those with lymphoma, and its development in those with myelodysplastic syndrom...
Autores principales: | Daitoku, Shinya, Aoyagi, Tomomi, Takao, Shinichiro, Tada, Seiya, Kuroiwa, Mika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232014/ https://www.ncbi.nlm.nih.gov/pubmed/29780114 http://dx.doi.org/10.2169/internalmedicine.0497-17 |
Ejemplares similares
-
Hemophagocytic lymphohistiocytosis and myelodysplastic syndrome: a case report and review of the literature
por: Sun, Y., et al.
Publicado: (2021) -
Hemophagocytic Lymphohistiocytosis Syndromes
por: Standage, Stephen W., et al.
Publicado: (2014) -
Safety and efficacy of azacitidine in myelodysplastic syndromes
por: Vigil, Carlos E, et al.
Publicado: (2010) -
Hemophagocytic Lymphohistiocytosis
por: Kaçar, Ayşe Gonca, et al.
Publicado: (2022) -
A Case of Secondary Leukemia Subsequent to Myelodysplastic Syndromes Successfully Treated with Azacitidine
por: Kumode, Takahiro, et al.
Publicado: (2014)